de Groote P - Search Results

1

New technologies, new therapies: toward personalized medicine in heart failure patients?

de Groote P, Pinet F, Bauters C. de Groote P, et al. Eur Heart J. 2013 Mar;34(9):636-7. doi: 10.1093/eurheartj/ehs432. Epub 2012 Dec 20. Eur Heart J. 2013. PMID: 23257952 No abstract available.

2

Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty?

Bauters C, de Groote P, Adamantidis M, Delcayre C, Hamon M, Lablanche JM, Bertrand ME, Dupuis B, Swynghedauw B. Bauters C, et al. Among authors: de groote p. Eur Heart J. 1992 Apr;13(4):556-9. doi: 10.1093/oxfordjournals.eurheartj.a060213. Eur Heart J. 1992. PMID: 1534754

3

Influence of diabetes mellitus on heart failure risk and outcome.

Bauters C, Lamblin N, Mc Fadden EP, Van Belle E, Millaire A, de Groote P. Bauters C, et al. Among authors: de groote p. Cardiovasc Diabetol. 2003 Jan 8;2:1. doi: 10.1186/1475-2840-2-1. Cardiovasc Diabetol. 2003. PMID: 12556246 Free PMC article.

4

Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitors.

Aumégeat V, Lamblin N, de Groote P, Mc Fadden EP, Millaire A, Bauters C, Lablanche JM. Aumégeat V, et al. Among authors: de groote p. Chest. 2003 Oct;124(4):1250-8. doi: 10.1378/chest.124.4.1250. Chest. 2003. PMID: 14555553

5

[Endothelin-1 receptor antagonists in heart failure].

de Groote P, Lamblin N, Bauters C. de Groote P, et al. Arch Mal Coeur Vaiss. 2003 Oct;96(10):984-7. Arch Mal Coeur Vaiss. 2003. PMID: 14653059 Review. French.

6

Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure.

de Groote P, Helbecque N, Lamblin N, Hermant X, Amouyel P, Bauters C, Dallongeville J. de Groote P, et al. Eur J Heart Fail. 2004 Jan;6(1):17-21. doi: 10.1016/j.ejheart.2003.09.006. Eur J Heart Fail. 2004. PMID: 15012914 Free article.

7

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, Bauters C. De Groote P, et al. Eur Heart J. 2004 Apr;25(8):656-62. doi: 10.1016/j.ehj.2004.01.010. Eur Heart J. 2004. PMID: 15084370

8

Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction.

Mizon-Gérard F, de Groote P, Lamblin N, Hermant X, Dallongeville J, Amouyel P, Bauters C, Helbecque N. Mizon-Gérard F, et al. Among authors: de groote p. Eur Heart J. 2004 Apr;25(8):688-93. doi: 10.1016/j.ehj.2004.01.015. Eur Heart J. 2004. PMID: 15084374

9

B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.

de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. de Groote P, et al. J Am Coll Cardiol. 2004 May 5;43(9):1584-9. doi: 10.1016/j.jacc.2003.11.059. J Am Coll Cardiol. 2004. PMID: 15120815 Free article.

10

Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?

de Groote P, Soudan B, Lamblin N, Rouaix-Emery N, Mc Fadden E, Meurice T, Mouquet F, Bauters C. de Groote P, et al. Am Heart J. 2004 Aug;148(2):349-55. doi: 10.1016/j.ahj.2004.03.044. Am Heart J. 2004. PMID: 15309008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters